DEC 02, 2015 5:05 PM PST

A New Remedy for Whooping Cough

WRITTEN BY: Kerry Evans
Researchers at The University of Texas at Austin, in collaboration with Synthetic Biologics Inc., developed an antibody-based therapy for whooping cough.

Whooping cough is a bacterial infection caused by Bordetella pertussis.  Antibiotics are not always effective and it is highly contagious, infecting nearly 16 million people each year worldwide.  B. pertussis is particularly virulent because it produces a toxin.  Pertussis toxin (PT) enters cells where it prevents G proteins from interacting with G protein-coupled receptors, shutting down many vital cellular processes. PT also causes lymphocytosis, an increase in white blood cells in the blood.  These white blood cells interfere with lung function and contribute to the characteristic cough.  While there is a vaccine, it is not licensed for use in infants under 6 weeks of age.
 
Whooping cough is caused by Bordetella pertussis.
 
With this in mind, the University of Texas researchers, led by chemical engineer Jennifer Maynard, developed two antibodies that neutralize PT.  The antibodies bind the toxin, preventing it from attaching to and entering cells.  When the group injected mice with the antibodies then infected them with B. pertussis, they were protected from infection.  The group then infected non-human primates and administered the antibodies.  In this case, the antibody treatment decreased white blood cell levels and sped up recovery.    
According to Maynard, “in the developing world, an estimated 200,000 babies die a year, and that's where we think we can have a really big impact … if we can get our antibodies to these high-risk infants, we could potentially prevent the infection from occurring in the first place”.  The group licensed the antibodies to Synthetic Biologics Inc., and they hope to begin human clinical trials soon.  

While this new antibody-based therapy sounds promising, I’m left with a lingering question.  Will Synthetic Biologics be able to distribute their antibody therapy to the developing world even though (evidently) the whooping cough vaccine hasn’t made it there?  Guess we’ll wait and see.

Sources: Eurekalert, Synthetic Biologics, Inc., Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 24, 2019
Microbiology
NOV 24, 2019
Scientists Find the Limits of Life in an Extreme Environment
Different forms of microbes have been able to make a home even in the harshest conditions. But there are still locations where they can't live....
DEC 30, 2019
Microbiology
DEC 30, 2019
Understanding How Microbes in the Body Function as a Community
Advances in genetic technologies made it possible for researchers to learn more about the vast community of microbes that resides in the human body....
JAN 14, 2020
Microbiology
JAN 14, 2020
Bacterial Growth That is Truly Cultured
Scientists have learned that when certain bacteria are paired together, they create patterns that look like flowers....
JAN 17, 2020
Cardiology
JAN 17, 2020
Eating Walnuts Reduces Risk for Heart Disease
Walnuts may be more than just a tasty snack. Researchers from the University of Pennsylvania have found that they may also promote healthy gut bacteria, wh...
JAN 26, 2020
Microbiology
JAN 26, 2020
The Planet's Soil is Home to Microbe-Eating Protists
Protists don't fit neatly into any other category of organism; they are eukaryotes, but they are not a plant, fungi or animal....
FEB 17, 2020
Microbiology
FEB 17, 2020
Giant Viruses Blur the Line Between Life and Non-Life
Bacteriophages, also known as phages, are more complex than many viruses that we know of, and often carry large genomes....
Loading Comments...